HUMA Stock Analysis: Buy, Sell, or Hold?
HUMA - Humacyte, Inc. Common Stock
$1.02
0.02 (2.24%)
▲
5d:
+0.0%
30d:
+6.19%
90d:
-37.04%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 26, 2026
Get Alerted When HUMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called HUMA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HUMA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HUMA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HUMA is currently trading at $1.02, which is considered slightly low relative to its 30-day fair value range of $1.00 to $1.13.
Technical Outlook: Technically, HUMA is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.15.
Market Sentiment: HUMA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.71 (+656.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HUMA is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.15.
Market Sentiment: HUMA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.71 (+656.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.00 -
$1.13
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 656.3% below Wall St target ($7.71)
Fair Price Analysis
30-Day Fair Range
$1.00 -
$1.13
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.15
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.94
Wall Street Target
$7.71
(+656.3%)
Revenue Growth (YoY)
-100.0%
Last updated: February 02, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HUMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady W Dougan
SELL
591685 shares
2025-08-20
Laura E Niklason
SELL
591685 shares
2025-08-20
Brady W Dougan
SELL
1100000 shares
2025-08-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 62 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 60 HOLD |
